US Broker Ratings

Legend Biotech Corporation (LEGN) Stock Analysis: A Promising Biotech with a Potential Upside of 106%

Legend Biotech Corporation (NASDAQ: LEGN), a burgeoning force in the biotech sector, is catching the eye of investors with its robust growth potential and strategic focus..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Evaluating a 24.85% Potential Upside Amidst Biotech Volatility

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a key player in the biotechnology sector, is at a pivotal point that presents a unique opportunity for investors. With its..

BrightSpring Health Services (BTSG) Stock Analysis: Healthcare Innovator with 38% Upside Potential

BrightSpring Health Services, Inc. (BTSG) has captured the attention of investors with its robust growth prospects and a compelling potential upside of 38.15%. As a key..

Exact Sciences Corporation (EXAS) Stock Analysis: A 56% Potential Upside in the Healthcare Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS) stands as a prominent player in the healthcare sector, specifically in diagnostics and research. With a market capitalization of $7.76 billion,..

Masimo Corporation (MASI): Investor Outlook on a 29.6% Potential Upside

Masimo Corporation (NASDAQ: MASI) stands out as a compelling investment opportunity in the healthcare sector, particularly in the medical devices industry. Headquartered in Irvine, California, Masimo..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Biotech Gem with 42% Upside Potential

Soleno Therapeutics, Inc. (NASDAQ: SLNO) presents an intriguing opportunity for investors keen on the biotechnology sector, particularly those focused on companies developing treatments for rare diseases...

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Biotech Pioneer with 101% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), a prominent player in the biotechnology sector, continues to capture investor attention, not only due to its promising pipeline of radiopharmaceuticals..

Qiagen N.V. (QGEN) Stock Analysis: Navigating Potential 8.76% Upside in Diagnostics & Research

For individual investors keeping an eye on the healthcare sector, Qiagen N.V. (NYSE: QGEN) presents a compelling opportunity within the diagnostics and research industry. Based in..

Neurocrine Biosciences (NBIX) Stock Analysis: A 34% Upside Potential in the Healthcare Sector

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) has captured the attention of investors with its robust performance in the healthcare sector, particularly in the field of neurological, neuroendocrine,..

HealthEquity, Inc. (HQY) Stock Analysis: A 31% Upside Potential for Investors

HealthEquity, Inc. (HQY), a prominent player in the Health Information Services industry, is making waves with its robust technology-enabled service platforms targeted at consumers and employers..

Akero Therapeutics, Inc. (AKRO): Analyst Consensus Suggests 51% Upside Potential

Akero Therapeutics, Inc. (NASDAQ: AKRO) is capturing investor attention in the healthcare sector, with a market capitalization of $4.02 billion and a strong focus on biotechnology...

Bruker Corporation (BRKR): Investor Outlook on a Stock with 53.56% Potential Upside

Bruker Corporation (NASDAQ: BRKR) stands as a noteworthy player within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $4.62 billion,..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 73% Potential Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH) is currently captivating the attention of investors with its robust portfolio in the healthcare sector, particularly in the drug manufacturing industry..

Alkermes plc (ALKS) Stock Analysis: Exploring a 55% Potential Upside with Robust Analyst Confidence

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, particularly within the drug manufacturers’ specialty and generic industries, presents a compelling investment case for..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 24.98% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR), a heavyweight in the healthcare sector, is firmly positioned in the drug manufacturing industry with a specialization in both specialty and..

ICON plc (ICLR) Stock Analysis: Unveiling a 38.1% Upside Opportunity in Healthcare Research

Investors seeking opportunities in the healthcare sector may want to take a closer look at ICON plc (NASDAQ: ICLR), a key player in the diagnostics and..

Glaukos Corporation (GKOS) Stock Analysis: A 44.67% Potential Upside Amidst Healthcare Innovations

Glaukos Corporation (NYSE: GKOS) is making waves in the healthcare sector with its innovative solutions for treating eye diseases. The company, headquartered in Aliso Viejo, California,..

Chemed Corp (CHE) Stock Analysis: A Lucrative 30% Upside Awaits Investors

Chemed Corp (NYSE: CHE) is a compelling investment opportunity in the healthcare sector, primarily due to its potential upside of 30.30%, as indicated by analyst ratings...

Bausch + Lomb (BLCO): Investor Outlook on a Healthcare Stalwart with 11% Potential Upside

Bausch + Lomb Corporation (BLCO) stands as a historic pillar in the healthcare sector, particularly within the medical instruments and supplies industry. With its roots tracing..

Axsome Therapeutics, Inc. (AXSM): Investor Outlook with a Potential 68.84% Upside

Investors looking for a compelling opportunity in the healthcare sector may find Axsome Therapeutics, Inc. (NASDAQ: AXSM) an intriguing prospect. As a biopharmaceutical company dedicated to..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds